Z-1359-2019 Class III Terminated
FDA device recall Z-1359-2019 was initiated by Abbott Laboratories on Apr 9, 2019 and is designated Class III. Reason for recall: Devices were delivered without the required dry ice. The recall status is terminated (terminated Dec 20, 2019). Affected quantity: 2 units.
Recall details
- Product Type
- Devices
- Report Date
- May 22, 2019
- Initiation Date
- Apr 9, 2019
- Termination Date
- Dec 20, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2 units
Product description
ARCHITECT STAT High Sensitive Troponin-I Controls - Product Usage: The ARCHITECT STAT High Sensitive Troponin-I Controls are for the estimation of test precision and the detection of systematic analytical deviations of the ARCHITECT i System with STAT protocol capability when used for the quantitative determination of cardiac troponin I (cTnI) in human serum and plasma with the ARCHITECT STAT High Sensitive Troponin-I reagent kit.
Reason for recall
Devices were delivered without the required dry ice.
Distribution pattern
Distribution to Latvia.
Code information
LN 3P25-11; Lot 94347UIOO
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1359-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026